188 related articles for article (PubMed ID: 24009132)
1. Phospholipid-dependent procoagulant activity is highly expressed by circulating microparticles in patients with essential thrombocythemia.
Marchetti M; Tartari CJ; Russo L; Panova-Noeva M; Leuzzi A; Rambaldi A; Finazzi G; Woodhams B; Falanga A
Am J Hematol; 2014 Jan; 89(1):68-73. PubMed ID: 24009132
[TBL] [Abstract][Full Text] [Related]
2. Thrombin generation and procoagulant phospholipids in patients with essential thrombocythemia and reactive thrombocytosis.
Mignon I; Grand F; Boyer F; Hunault-Berger M; Hamel JF; Macchi L
Am J Hematol; 2013 Dec; 88(12):1007-11. PubMed ID: 23873831
[TBL] [Abstract][Full Text] [Related]
3. The evaluation of the relevance of thrombin generation and procoagulant activity in thrombotic risk assessment in BCR-ABL-negative myeloproliferative neoplasm patients.
Baccouche H; Ben Jemaa M; Chakroun A; Chadi S; Mahjoub S; Sfar I; Gorgi Y; Ben Romdhane N
Int J Lab Hematol; 2017 Oct; 39(5):502-507. PubMed ID: 28497580
[TBL] [Abstract][Full Text] [Related]
4. VIIaAT complexes, procoagulant phospholipids, and thrombin generation during postprandial lipemia.
Silveira A; Carlo A; Adam M; McLeod O; Lundman P; Boquist S; Woodhams BJ; Hamsten A
Int J Lab Hematol; 2018 Jun; 40(3):251-257. PubMed ID: 29356352
[TBL] [Abstract][Full Text] [Related]
5. Platelet-induced thrombin generation by the calibrated automated thrombogram assay is increased in patients with essential thrombocythemia and polycythemia vera.
Panova-Noeva M; Marchetti M; Spronk HM; Russo L; Diani E; Finazzi G; Salmoiraghi S; Rambaldi A; Barbui T; Ten Cate H; Falanga A
Am J Hematol; 2011 Apr; 86(4):337-42. PubMed ID: 21442635
[TBL] [Abstract][Full Text] [Related]
6. Increased circulating procoagulant activity and thrombin generation in patients with myeloproliferative neoplasms.
Duchemin J; Ugo V; Ianotto JC; Lecucq L; Mercier B; Abgrall JF
Thromb Res; 2010 Sep; 126(3):238-42. PubMed ID: 20656333
[TBL] [Abstract][Full Text] [Related]
7. Procoagulant activity, but not number, of microparticles increases with age and in individuals after a single venous thromboembolism.
Owen BA; Xue A; Heit JA; Owen WG
Thromb Res; 2011 Jan; 127(1):39-46. PubMed ID: 21106230
[TBL] [Abstract][Full Text] [Related]
8. ADP-induced platelet aggregation and thrombin generation are increased in Essential Thrombocythemia and Polycythemia Vera.
Panova-Noeva M; Marchetti M; Russo L; Tartari CJ; Leuzzi A; Finazzi G; Rambaldi A; ten Cate H; Falanga A
Thromb Res; 2013 Jul; 132(1):88-93. PubMed ID: 23735588
[TBL] [Abstract][Full Text] [Related]
9. Elevated procoagulant microparticles expressing endothelial and platelet markers in essential thrombocythemia.
Trappenburg MC; van Schilfgaarde M; Marchetti M; Spronk HM; ten Cate H; Leyte A; Terpstra WE; Falanga A
Haematologica; 2009 Jul; 94(7):911-8. PubMed ID: 19508974
[TBL] [Abstract][Full Text] [Related]
10. Coagulation activation and microparticle-associated coagulant activity in cancer patients. An exploratory prospective study.
van Doormaal F; Kleinjan A; Berckmans RJ; Mackman N; Manly D; Kamphuisen PW; Richel DJ; Büller HR; Sturk A; Nieuwland R
Thromb Haemost; 2012 Jul; 108(1):160-5. PubMed ID: 22535219
[TBL] [Abstract][Full Text] [Related]
11. Prospective Assessment of Clinical Risk Factors and Biomarkers of Hypercoagulability for the Identification of Patients with Lung Adenocarcinoma at Risk for Cancer-Associated Thrombosis: The Observational ROADMAP-CAT Study.
Syrigos K; Grapsa D; Sangare R; Evmorfiadis I; Larsen AK; Van Dreden P; Boura P; Charpidou A; Kotteas E; Sergentanis TN; Elalamy I; Falanga A; Gerotziafas GT
Oncologist; 2018 Nov; 23(11):1372-1381. PubMed ID: 30104289
[TBL] [Abstract][Full Text] [Related]
12. The acceleration of the propagation phase of thrombin generation in patients with steady-state sickle cell disease is associated with circulating erythrocyte-derived microparticles.
Gerotziafas GT; Van Dreden P; Chaari M; Galea V; Khaterchi A; Lionnet F; Stankovic-Stojanovic K; Blanc-Brude O; Woodhams B; Maier-Redelsperger M; Girot R; Hatmi M; Elalamy I
Thromb Haemost; 2012 Jun; 107(6):1044-52. PubMed ID: 22535498
[TBL] [Abstract][Full Text] [Related]
13. Activation of the tissue factor-dependent extrinsic pathway and its relation to JAK2 V617F mutation status in patients with essential thrombocythemia.
Gadomska G; Stankowska K; Boinska J; Bartoszewska-Kubiak A; Haus O; Rość D
Blood Coagul Fibrinolysis; 2016 Oct; 27(7):817-821. PubMed ID: 26945263
[TBL] [Abstract][Full Text] [Related]
14. Tissue factor procoagulant activity of plasma microparticles is increased in patients with early-stage prostate cancer.
Haubold K; Rink M; Spath B; Friedrich M; Chun FK; Marx G; Amirkhosravi A; Francis JL; Bokemeyer C; Eifrig B; Langer F
Thromb Haemost; 2009 Jun; 101(6):1147-55. PubMed ID: 19492160
[TBL] [Abstract][Full Text] [Related]
15. Hypercoagulability in overweight and obese subjects who are asymptomatic for thrombotic events.
Campello E; Zabeo E; Radu CM; Spiezia L; Gavasso S; Fadin M; Woodhams B; Vettor R; Simioni P
Thromb Haemost; 2015 Jan; 113(1):85-96. PubMed ID: 25318550
[TBL] [Abstract][Full Text] [Related]
16. V617F JAK-2 mutation in patients with essential thrombocythemia: relation to platelet, granulocyte, and plasma hemostatic and inflammatory molecules.
Falanga A; Marchetti M; Vignoli A; Balducci D; Russo L; Guerini V; Barbui T
Exp Hematol; 2007 May; 35(5):702-11. PubMed ID: 17577920
[TBL] [Abstract][Full Text] [Related]
17. Procoagulant microparticles promote coagulation in a factor XI-dependent manner in human endotoxemia.
Mooberry MJ; Bradford R; Hobl EL; Lin FC; Jilma B; Key NS
J Thromb Haemost; 2016 May; 14(5):1031-42. PubMed ID: 26857798
[TBL] [Abstract][Full Text] [Related]
18. Impact of Epicatechin on the Procoagulant Activities of Microparticles.
Sinegre T; Milenkovic D; Bourgne C; Teissandier D; Nasri Y; Dannus LT; Morand C; Lebreton A
Nutrients; 2020 Sep; 12(10):. PubMed ID: 32992756
[TBL] [Abstract][Full Text] [Related]
19. Contact activation: important to consider when measuring the contribution of tissue factor-bearing microparticles to thrombin generation using phospholipid-containing reagents.
Boknäs N; Faxälv L; Lindahl TL; Ramström S
J Thromb Haemost; 2014 Apr; 12(4):515-8. PubMed ID: 24405583
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy-induced thrombin generation via procoagulant endothelial microparticles is independent of tissue factor activity.
Lechner D; Kollars M; Gleiss A; Kyrle PA; Weltermann A
J Thromb Haemost; 2007 Dec; 5(12):2445-52. PubMed ID: 17922809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
